JP2016516072A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516072A5
JP2016516072A5 JP2016503369A JP2016503369A JP2016516072A5 JP 2016516072 A5 JP2016516072 A5 JP 2016516072A5 JP 2016503369 A JP2016503369 A JP 2016503369A JP 2016503369 A JP2016503369 A JP 2016503369A JP 2016516072 A5 JP2016516072 A5 JP 2016516072A5
Authority
JP
Japan
Prior art keywords
contrast medium
formulation
enteric
intestinal
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016503369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/030295 external-priority patent/WO2014145509A1/en
Publication of JP2016516072A publication Critical patent/JP2016516072A/ja
Publication of JP2016516072A5 publication Critical patent/JP2016516072A5/ja
Pending legal-status Critical Current

Links

JP2016503369A 2013-03-15 2014-03-17 低z原子による腸管ct造影材料 Pending JP2016516072A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361798392P 2013-03-15 2013-03-15
US201361790734P 2013-03-15 2013-03-15
US61/798,392 2013-03-15
US61/790,734 2013-03-15
PCT/US2014/030295 WO2014145509A1 (en) 2013-03-15 2014-03-17 Enteric ct contrast material based on low-z atoms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018038401A Division JP6843787B2 (ja) 2013-03-15 2018-03-05 低z原子による腸管ct造影材料

Publications (2)

Publication Number Publication Date
JP2016516072A JP2016516072A (ja) 2016-06-02
JP2016516072A5 true JP2016516072A5 (enExample) 2017-04-20

Family

ID=51530440

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016503369A Pending JP2016516072A (ja) 2013-03-15 2014-03-17 低z原子による腸管ct造影材料
JP2018038401A Active JP6843787B2 (ja) 2013-03-15 2018-03-05 低z原子による腸管ct造影材料
JP2020144080A Pending JP2020193223A (ja) 2013-03-15 2020-08-28 低z原子による腸管ct造影材料

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018038401A Active JP6843787B2 (ja) 2013-03-15 2018-03-05 低z原子による腸管ct造影材料
JP2020144080A Pending JP2020193223A (ja) 2013-03-15 2020-08-28 低z原子による腸管ct造影材料

Country Status (6)

Country Link
US (1) US11033640B2 (enExample)
EP (2) EP3984560A1 (enExample)
JP (3) JP2016516072A (enExample)
CN (2) CN108743976B (enExample)
ES (1) ES2897624T3 (enExample)
WO (1) WO2014145509A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033640B2 (en) 2013-03-15 2021-06-15 The Regents Of The University Of California Enteric CT contrast material based on low-z atoms
JP2016528259A (ja) 2013-08-16 2016-09-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シリコーン系腸管ct造影材料
ES2890328T3 (es) 2015-04-20 2022-01-18 Univ California Gas encapsulado o material de contraste de CT de vacío parcial
US20200179539A1 (en) * 2016-06-22 2020-06-11 Board Of Regents, The University Of Texas System Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation
EP3551231A4 (en) * 2016-12-08 2020-08-12 The Brigham and Women's Hospital, Inc. BISMUTH-GADOLINIUM NANOPARTICLES
CN109100775B (zh) * 2018-07-06 2020-05-29 郑州云海信息技术有限公司 一种双层探测器的能量谱校正方法与装置
JP2020103571A (ja) * 2018-12-27 2020-07-09 キヤノンメディカルシステムズ株式会社 医用処理装置及びx線診断システム
US20220401587A1 (en) * 2021-05-05 2022-12-22 The Regents Of The University Of California Low x-ray attenuation change hard shelled oral contrast material
WO2024086131A1 (en) * 2022-10-18 2024-04-25 The Johns Hopkins University Systems and methods for angiography using multi-energy detectors

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592185A (en) * 1967-04-18 1971-07-13 Yeda Res & Dev Ferromagnetic contrast media and method of use
US4615879A (en) 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
JPS6238172A (ja) 1985-08-12 1987-02-19 株式会社 高研 抗血栓性医用材料の製造方法
DE3709851A1 (de) 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
IL82834A (en) 1987-06-09 1990-11-05 Yissum Res Dev Co Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
GB9006671D0 (en) 1990-03-24 1990-05-23 Univ Manchester Diagnostic method and compositions
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
US5323780A (en) * 1992-08-07 1994-06-28 University Of Florida Research Foundation, Inc. Artifact-free imaging contrast agent
US5318769A (en) 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5472682A (en) 1993-03-31 1995-12-05 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
CN1146159A (zh) 1994-02-25 1997-03-26 耐克麦德英梅金公司 含有纤维素衍生物的x-射线造影组合物
WO1995028969A1 (en) 1994-04-21 1995-11-02 Nycomed Imaging As X-ray contrast compositions containing pharmaceutically acceptable clays
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US6818199B1 (en) * 1994-07-29 2004-11-16 James F. Hainfeld Media and methods for enhanced medical imaging
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
GB9603547D0 (en) 1996-02-20 1996-04-17 Nycomed Imaging As Contrast media
CA2327816A1 (en) * 1998-04-09 1999-10-21 Nycomed Imaging As Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
NO20052429D0 (no) * 2005-05-20 2005-05-20 Amersham Health As Konstrastmidler
GB0519391D0 (en) 2005-09-22 2005-11-02 Aion Diagnostics Ltd Imaging agents
US20070258907A1 (en) * 2006-04-24 2007-11-08 Davis Mark E Polymer-coated paramagnetic particles
EP2127682A1 (en) * 2008-05-28 2009-12-02 Deutsches Krebsforschungszentrum X-ray contrast agent based on bismuth oxide-nanoparticles
CN103261186A (zh) 2010-12-13 2013-08-21 诺瓦提斯公司 二聚化iap抑制剂
RU2013125324A (ru) 2010-12-15 2015-01-20 Дженерал Электрик Компани Композиция наночастиц и связанные с ней способы
SG192181A1 (en) * 2011-01-28 2013-08-30 Univ Dalhousie Radiopaque embolic particles
EP3492116B1 (en) 2011-06-06 2022-03-23 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Portland State University Bismuth particle x-ray contrast agents
CN104736184A (zh) * 2012-06-04 2015-06-24 米格拉塔英国有限公司 钛和/或氧化钛的颗粒的医学用途
US11033640B2 (en) 2013-03-15 2021-06-15 The Regents Of The University Of California Enteric CT contrast material based on low-z atoms
JP2016528259A (ja) * 2013-08-16 2016-09-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シリコーン系腸管ct造影材料

Similar Documents

Publication Publication Date Title
Maisel et al. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
Poinard et al. Polydopamine coating enhances mucopenetration and cell uptake of nanoparticles
Oshi et al. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease
Cho et al. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications
Cu et al. Controlled surface modification with poly (ethylene) glycol enhances diffusion of PLGA nanoparticles in human cervical mucus
Luo et al. Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan―alginate matrix by combining layer-by-layer assembly with CaCl2 cross-linking for an effective treatment of inflammatory bowel diseases
US9597419B2 (en) Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
JP2022003054A (ja) カプセル化された気体または部分真空のct造影材料
Cook et al. Microencapsulation of a synbiotic into PLGA/alginate multiparticulate gels
JP2015519330A5 (enExample)
US20080243113A1 (en) Modification of stent surfaces to impart functionality
CN110408047B (zh) 纳米配位聚合物及其制备方法和应用
JP6846351B2 (ja) 粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤
Lim et al. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors
Lee et al. Drug‐loaded mucoadhesive patch with active delivery and controlled releasing ability
JP2018090624A (ja) 低z原子による腸管ct造影材料
Go et al. A soft biodegradable chitosan‐based medical microrobot with optimized structural design and X‐ray visibility for targeted vessel chemoembolization
CN103120795B (zh) 一种靶向巨噬细胞的制剂
WO2015127389A1 (en) Hypotonic enema formulations and methods of use
Ali et al. Advances in nanoparticles as anticancer drug delivery vector: need of this century
Zhao et al. Oral delivery of ultra-small zwitterionic nanoparticles to overcome mucus and epithelial barriers for macrophage modulation and colitis therapy
Enwereuzo et al. Self-assembled membrane-polymer nanoparticles of top-notch tissue tolerance for the treatment of gastroesophageal reflux disease
Fathi Kisomi et al. Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection
ES2670925T3 (es) Agente de contraste para IRM que contiene partículas de material compuesto
Kabha et al. Biodegradable controlled-release device for localized chemotherapeutic treatment of bladder cancer